Amir Hassan Navaei, MD

Dr. Navaei is a board-certified Pediatric Intensivist with expertise in the care of critically ill children, including those requiring extracorporeal life support such as extracorporeal membrane oxygenation (ECMO) and ventricular assist devices. He is board-certified in Transfusion Medicine and Coagulation and provides specialized consultation on anticoagulation, transfusion support and the management of bleeding and thrombotic complications in patients receiving extracorporeal support. He also serves as a consultant for apheresis services.

[person:personal_statement]

I am committed to providing thoughtful, evidence-based care to critically ill children with a focus on safety, precision and collaboration. I view patient care as a partnership with families and multidisciplinary teams in which clear communication and mutual trust are essential to making complex decisions, especially in high-risk settings such as ECMO and ventricular assist device (VAD) support. My approach emphasizes careful balance of optimizing anticoagulation while minimizing bleeding risk, tailored to each child’s unique physiology and clinical course. I strive to remain attentive, adaptable and compassionate, recognizing the stress families face during critical illness.

Intereses Clinicos

Pediatric Hemostasis and Thrombosis, Massive Transfusion, Extracorporeal Support

Educacion

Organizaciones

Board Certifications

Honors and awards

2021-2022

M. Vicky Gresik Faculty Award, Outstanding Resident Teaching in Clinical Pathology

* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.

Research interests

Understanding the mechanisms underlying coagulopathy in critically ill children and developing safe, evidence-based strategies to improve patient outcomes

Singleton L, Kennedy C, Philip B, Navaei A, Bhar S, Ankola A, Doane K, Ontaneda A. Use of Inhaled Tranexamic Acid for Pulmonary Hemorrhage in Pediatric Patients on Extracorporeal Membrane Oxygenation Support. ASAIO Journal, 2025 Nov 1;71(11):944-951. doi: 10.1097/MAT.0000000000002430. Epub 2025 Apr 7. PMID: 40193587

Navaei A, Kostousov V, Teruya J. Is it time to switch to bivalirudin for ECMO anticoagulation? Frontiers in Medicine, 2023 Aug 21;10:1237601. doi: 10.3389/fmed. 2023.1237601. PMID: 37671395; PMCID: PMC10476497

Singleton L, Kennedy C, Philip B, Navaei A, Bhar S, Ankola A, Ontaneda A. Inhaled tranexamic acid use for pulmonary hemorrhage in children on ECMO. JAAPA, 2023 Dec 1;36(12):1. doi: 10.1097/01.JAA.0000995012.09070.cb. PMID: 37989189

Gollamudi J, Sartain SE, Navaei AH, Aneja S, Kaur Dhawan P, Tran D, Joshi J, Gidudu J, Gollamudi J, Chiappini E, Varricchio F, Law B, Munoz FM. Thrombosis and thromboembolism: Brighton collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine, 2022 Oct 19;40(44):6431-6444. doi: 10.1016/j.vaccine.2022.09.001. Epub 2022 Sep 20. PMID: 36150973

Navaei AH, Shekerdemian LS, Mohammad MA, Coss-Bu JA, Bastero P, Ettinger NA, Orellana R, Fernandes CJ, Marini JC. Derangement of Arginine and Related Amino Acids in Children Undergoing Surgery for Congenital Heart Disease With Cardiopulmonary Bypass. Critical Care Explorations, 2020 Jul 16;2(7):e0150. doi: 10.1097/CCE.0000000000000150. PMID: 32766551; PMCID: PMC7368881

Fang ZA, Navaei AH, Hensch L, Hui SR, Teruya J. Hemostatic Management of Extracorporeal Circuits Including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation. Seminars in Thrombosis and Hemostasis, 2020 Feb;46(1):62-72. doi: 10.1055/s-0039-3400273. Epub 2019 Dec 13. PMID: 31858515